InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,572.85
(
0.10%
)
US TECH 100
19,968.00
(
0.37%
)
Dow Jones
39,344.79
(
-0.08%
)
Brent Oil
85.15
(
-0.31%
)
Bitcoin
57,318.25
(
1.08%
)
Post# of 463814
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

RedShoulder

Send PM Follow Ignore
Followers 156
Posts 6368
Boards Moderated 1
Alias Born 08/06/2004

RedShoulder

Member Level

Re: nidan7500 post# 413419

Tuesday, 05/02/2023 2:26:40 PM

Tuesday, May 02, 2023 2:26:40 PM

Post# of 463814
Anyone in the trials getting a 30mg or 50mg daily dose of A2-73 or A3-71 for the treatment of a particular disease, they are also treating all the organs at the same time with the S1-R in homeostasis with the mitochondria.

In the present and past trials of 2-73 Blarcamesine treating either for AD, PDD, PD, or Rett , they are also potentially treating the heart, lungs, liver, kidneys, colon, eyes. etc. for some degree of improvement. Anywhere where the Mitochondria is found there will be S-1R present; which is about the entire body, with the exception of the red red blood cells that contain neither nucleus nor mitochondria and therefore does not use the oxygen it is transporting.
Bullish
Bullish

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM

BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM

NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

Start posting your company's news
Only $200 per official company press release!